Search Within

Khedoudja Nafa

  1. "Myeloma"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Center for Hematologic Malignancies (5)
  2. Department of Medicine (5)
  3. Department of Pathology and Laboratory Medicine (5)
  4. Hematologic Malignancies Research (5)
  5. Hematologic Malignancies, Division of (5)
  6. Myeloma (5)

More Groups

People
  1. Caleb Ho (5)
  2. Carl Landgren (5)
  3. Jinjuan Yao (5)
  4. Kseniya Petrova-Drus (5)
  5. Maria Arcila (5)
  6. Mikhail Roshal (5)

More People

Years
  1. 2021 (1)
  2. 2019 (2)
  3. 2018 (1)
  4. 2017 (1)
Publications
  1. Blood (3)
  2. Journal of Molecular Diagnostics (2)
Publishers
  1. American Society of Hematology (3)
  2. Elsevier Science, Inc. (2)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Routine evaluation of minimal residual disease in myeloma using next-generation sequencing clonality testing: Feasibility, challenges, and direct comparison with high-sensitivity flow cytometry
    Journal Article

    Ho, C.; Syed, M.; Roshal, M.; Petrova-Drus, K.; Moung, C.; Yao, J.; Quesada, A. E.; Benhamida, J.; Vanderbilt, C.; Liu, Y.; more...
    Journal of Molecular Diagnostics (2021)

    Fulltext@MSK | Save
  • Plasma cell myeloma residual disease quantitation using a next-generation sequencing-based IGH clonal rearrangement assay with the aid of a "spike-in" clonal sequence
    Meeting Abstract

    Ho, C.; Syed, M.; Yu, W.; Petrova-Drus, K.; Yao, J. J.; Moung, C.; Chang, J.; Benhamida, J.; Vanderbilt, C.; Roshal, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Establishment of immunoglobulin heavy (IGH) chain clonality testing by next-generation sequencing for routine characterization of B-cell and plasma cell neoplasms
    Journal Article

    Arcila, M. E.; Yu, W.; Syed, M.; Kim, H.; Maciag, L.; Yao, J.; Ho, C.; Petrova, K.; Moung, C.; Salazar, P.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Next-generation sequencing-based assay shows high clonal characterization success rate for plasma cell neoplasms, and concordance with flow cytometry in minimal residual disease detection
    Meeting Abstract

    Ho, C.; Syed, M.; Roshal, M.; Petrova-Drus, K.; Moung, C.; Yao, J. J.; Yu, W.; Maciag, L.; Benayed, R.; Hultcrantz, M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Next generation sequencing (NGS) based IGH and TCR clonality assays provide excellent specificity and sensitivity for routine clonal characterization and monitoring of lymphoproliferative disorders
    Meeting Abstract

    Arcila, M. E.; Syed, M.; Yu, W.; Kim, H.; Yao, J.; Ho, C.; Petrova-Drus, K.; Roshal, M.; Park, J. H.; Landgren, O.; more...
    Blood (2017)

    Fulltext@MSK | Save